INFOS !
  • NEW ADDRESS: The management team of ERN-EYE is moving! Starting from March 19, you can find us at 1 Rue Eugène Boeckel, 67000 Strasbourg.

Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Study of BEST1 Vitelliform Macular Dystrophy

In this page

Clinical Trial

NCT05809635 Recruiting, Active
Study of BEST1 Vitelliform Macular Dystrophy

Natural History Study in Retinitis Pigmentosa Caused by Mutations in the BEST1 Gene

Observational
Observational

Disease

Disease type

Other

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

30/03/2021

Closing date

31/05/2025

Inclusion criteria :

More

Exclusion criteria :

More

Funding

Public

Members involved

Others investigators

Pr Isabelle Audo

Representative

France

Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
See more

Pr Katarina Stingl

Representative

Germany

Low Vision Daily Life and Patients Groups (TWG5), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
Working Group Leader
See more

ERN EYE member investigating site

HCP : Others investigators

Centre for Ophthalmology, University Eye Hospital, Tübingen, Germany

Adress

Department für Augenheilkunde Tübingen Forschungsinstitut für Augenheilkunde Elfriede-Aulhorn-Str. 7

72076 Tübingen

Germany